+
Site Tour

R. Dworakowski "It's an ideal valve to be used for patients who may require future coronary interventions"

Discover what M. Van Wely, W-K. Kim, S. Khogali, M. Ozkor and R. Dworakowski think about Navitor™ and future interventions

Related Videos

Now you've got Navitor. Remarkable performance.

Now you've got Navitor.
Stable delivery.

TAVI Summit - TAVR in bicuspid

TAVI Case Club – Challenge of difficult access

Echo course mitral TEER – patient selection

TAVI Summit 2023: Aortic stenosis

TAVI Summit - Live case from Berlin

PremiClose 2024: Risks vs benefits of closure

TAVI Summit - What is coming next

TRENDING TOPICS

Navigating the Anatomy | Tricuspid focus

Navigating the Anatomy | Tricuspid focus

F. Maisano, V. Delgado, P. Denti, M. Taramasso

Review the Trends | Tricuspid focus

Review the Trends | Tricuspid focus

M. Metra, G. Leurent, D. Tchetche, T. Nestelberger, D. Cohen, M. Adamo

Case Transmission | Tricuspid focus

Case Transmission | Tricuspid focus

F. Maisano, M. I. Koerber, H. Dreger, R. Bekeredjian, K. K. Yeo, T. Matsumoto

CONNEXT


TV
RELATED RESOURCES

PCR London Valves 2022 – Tricuspid valve intervention

TriClip™: Device features

TAVI Summit - Cardiac imaging and morphology

ESC 2022: FMR

CONNEXT


HUB
RELATED RESOURCES

EXPAND Study: Data overview

ESC 2021: HF & VHD Guidelines

EuroEcho 2021: bRIGHT Gap Analysis

EuroEcho 2021: MR Treatment (Evidence)

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline